India Limits Markups on Critical Cancer Medicines to Protect Families from Financial Ruin

New Delhi, Saturday, 24 October 2026.
Prompted by Supreme Court scrutiny exposing extreme retail markups over 700%, India has capped profit margins at 30% across 137 cancer drugs, slashing prices by up to 70% starting November 2026.